Source: DGNews | Posted 8 years ago
FDA Approves Low Dose Premarin (Conjugated Estrogens Tablets)
Tags:
Expands Options for Menopausal Symptom Relief
MADISON, NJ -- April 28, 2003 -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) approved a new low dose strength of the Company's estrogen therapy. Premarin
Comments